Arthritis drug shows potential in skin cancer
The effectiveness of melanoma treatment could be boosted if combined with a well-known drug for rheumatoid arthritis (RA), indicates early UK research.
Read More
Tag: Oncotarget
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
